These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6018140)

  • 1. Sixth National Burn Seminar. Control of Pseudomonas infections by the immune processes.
    Feller I
    J Trauma; 1967 Jan; 7(1):93-5. PubMed ID: 6018140
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutical pseudomonas aeruginosa antisera. Preparation, control and administration.
    Meitert T; Meitert E; Szegli G; Peligrad I
    Arch Roum Pathol Exp Microbiol; 1982; 41(2):115-21. PubMed ID: 6816189
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-Pseudomonas immunoglobulin. IV. Combined anti-Pseudomonas immunoglobulin and Pseudomonas vaccine immunotherapy of burned patients--clinical investigations.
    Sakiel S; Schiller B; Buchowicz I; Lysakowska E; Tomanek E; Kruczałowa M; Przewdziecka M
    Arch Immunol Ther Exp (Warsz); 1984; 32(5):523-8. PubMed ID: 6534319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of human anti-Pseudomonas immunoglobulins in treatment of children with burns].
    Bukowska D; Wegrzynowicz Z; Rudowski W; Kraj M; Rosiek A; Gardzińska E; Popiel D
    Pol Tyg Lek; 1996 Jun; 51(23-26):331-3. PubMed ID: 9273523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Pseudomonas immunoglobulin. III. Preliminary clinical evaluation.
    Sakiel S; Schiller B; Buchowicz I; Kotkowska-Tomanek E
    Arch Immunol Ther Exp (Warsz); 1983; 31(4):517-21. PubMed ID: 6422901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathogenetic and immunotherapeutic significance of a cutaneous burn toxin in experimental pseudomonas infection].
    Postel J; Allgöwer M; Burkhart F; Müller W; Städtler K; Schoenenberger GA
    Helv Chir Acta; 1974 Mar; 41(1-2):7-11. PubMed ID: 4436111
    [No Abstract]   [Full Text] [Related]  

  • 7. [Development of immunological preparations and their use for preventing and treating pyocyanic infection in burn patients].
    Kolker II; Stanislavskiĭ ES; Grishina IA; Panova IuM; Krokhina MA
    Probl Gematol Pereliv Krovi; 1981 Jan; 26(1):29-33. PubMed ID: 6784114
    [No Abstract]   [Full Text] [Related]  

  • 8. Burn sepsis and burn toxin.
    Allgöwer M; Städtler K; Schoenenberger GA
    Ann R Coll Surg Engl; 1974 Nov; 55(5):226-35. PubMed ID: 4429330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A reduction of Pseudomonas septicemias in burned patients by the immune process.
    Pierson C; Feller I
    Surg Clin North Am; 1970 Dec; 50(6):1377-83. PubMed ID: 4922825
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune response of gnotobiotic animals to burn injury.
    Hummel RP; MacMillan BG; Altemeier WA; Hill EO
    Surg Forum; 1966; 17():84-6. PubMed ID: 5921048
    [No Abstract]   [Full Text] [Related]  

  • 11. [Current problems in the immunoprophylaxis and immunotherapy of burn infection].
    Kolker II
    Gematol Transfuziol; 1984 Jul; 29(7):9-12. PubMed ID: 6468913
    [No Abstract]   [Full Text] [Related]  

  • 12. Passive anti-PcrV treatment protects burned mice against Pseudomonas aeruginosa challenge.
    Neely AN; Holder IA; Wiener-Kronish JP; Sawa T
    Burns; 2005 Mar; 31(2):153-8. PubMed ID: 15683685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudomonas vaccine and hyperimmune plasma for burned patients.
    Feller I; Pierson C
    Arch Surg; 1968 Aug; 97(2):225-9. PubMed ID: 5657428
    [No Abstract]   [Full Text] [Related]  

  • 14. Active and passive mouse-protecting capacity of Pseudomonas aeruginosa protein vaccines.
    Joó I; Stanislavsky ES; Zhvanetskaya MI; Mashilova GM; Gladus MA
    Acta Microbiol Acad Sci Hung; 1982; 29(4):267-75. PubMed ID: 6821018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Protective effect of Pseudomonas-specific immunoglobulin from the rabbit and of active immunization in experimental Pseudomonas sepsis in mice].
    Trautmann M; Brückner O; Hahn H
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jul; 252(3):370-83. PubMed ID: 6215803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Protective action of various antibody preparations in experimental bacterial sepsis].
    Trautmann M; Brückner O; Hofstaetter T; Seiler FR; Hahn H
    Beitr Infusionther Klin Ernahr; 1982; 9():155-65. PubMed ID: 6816213
    [No Abstract]   [Full Text] [Related]  

  • 17. Sixth National Burn Seminar. A guide for fluid therapy in burn patient management.
    Feller I
    J Trauma; 1967 Jan; 7(1):74-5. PubMed ID: 6018136
    [No Abstract]   [Full Text] [Related]  

  • 18. Convalescent burn plasma therapy for severely burned children. Control study of 81 cases and tests for Pseudomonas antibodies.
    Bocanegra M; Hinostroza F; Bazan A; Velarde N; Yoza V; Rosenthal SM
    Ann Surg; 1966 Mar; 163(3):461-9. PubMed ID: 4955895
    [No Abstract]   [Full Text] [Related]  

  • 19. [Role and importance of immunotherapy in treating the infectious complications of burn patients].
    Panchenkov NR; Murazian RI
    Probl Gematol Pereliv Krovi; 1982 Feb; 27(2):46-8. PubMed ID: 7063469
    [No Abstract]   [Full Text] [Related]  

  • 20. Sixth National Burn Seminar. Introductory remarks.
    Boswick JA
    J Trauma; 1967 Jan; 7(1):67. PubMed ID: 6018133
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.